Upcoming events
There is no scheduled events at the moment.
Past events
From December 19, 2024 to December 19, 2024
Lallemand Pharma is thrilled to announce that Elisa Cauli, our esteemed QA & Technical Product Manager, represented Lallemand Pharma at the “International Workshop on Extremophiles: From Adaptive Strategies to Biotechnological Applications (II)”, hosted by the Research Center of Extreme Environments and Extremophiles (CUR-AEE) on December 19th, 2024, in Messina, Italy.
Elisa delivered an inspiring presentation titled “From Sea Depths to Industry Heights: Translating Biomarine Science into Industrial Innovation”.
Her insights highlighted how R&D focus drives product innovation and have significant effects on the entry of new drugs and medical devices with a positive impact for public health.
At Lallemand Pharma, we remain dedicated to advancing scientific research and developing innovative solutions that enhance respiratory health and well-being. 🌊🔬💡
Find more on the link below:
Location: Messina Italy
Webiste: https://curaee.unime.it/it
From September 12, 2024 to September 13, 2024
PharmaSynergyOTC, September 12-13, Paris, – is a partnering event that showcases the latest trends and developments connecting BD & Distribution executives across various regions. It connects global pharma BD & Licensing professionals, empowered further by the content-driven program.
The event showcases pharma opportunities for internationalization, in/out licensing, investment, and portfolio development.
It targets companies that believe science and innovation, and identifying new opportunities in this dynamic and highly competitive industry.
You can schedule a meeting by reaching us out though our website or social media!
Location: Paris
From September 08, 2023 to September 10, 2023
The XXIV National Conference of Allergists, Pulmonologists and Clinical Immunologists took place in Lublin, Poland from the 8th to the 9th of September.
This year the main objectives, have been to take a closer look at the latest diagnostic and therapeutic algorithms in bronchial asthma, new GINA and GOLD guidelines, new issues related to allergen immunotherapy and bacterial lysates, molecular diagnostics, RS virus infections or StethoMe electronic handset. There will also be novelties in aerosol therapy of respiratory diseases, allergic rhinitis therapy and lung ultrasound.
In the frame of the Congress Pr prof. dr hab. n. med. Andrzej Emeryk (Department of Children’s Lung Diseases and Rheumatology in Lublin, Poland) delivered a lecture about “Probiotics and postbiotics in respiratory tract infection and allergic rhinitis” in which illustrated the latest results of the clinical trial “Symbiofilm-TAK” – an observational study assessing the impact of adding Healsea™ isotonic nasal spray to conventional therapies for the care of IgE-dependent allergic children with symptoms of acute infections rhinitis.
The hypothesis of the study was Healsea™ isotonic nasal spray used on top of conventional therapies for common could have improved symptoms more efficiently and without any safety concerns. Results showed a superior efficacy of Healsea™ isotonic nasal spray as add-on treatment to SOC for common cold Significant reduction of the total WURSS-K (Wisconsin Upper Respiratory Symptom Survey- Kids) over 10 days in the Healsea isotonic group as compared to conventional therapies and a significant less frequent intake of common cold medication (and with shorter duration) in the Healsea™ group (overall, antibiotics, decongestants, nasal/inhaled corticosteroids).
Demonstrated also an excellent safety profile of Healsea™ nasal spray in a population of young allergic subjects.
Location: Lublin, Poland
From July 01, 2023 to July 07, 2023
The 19th World Congress of Basic & Clinical Pharmacology 2023 is taking place in Glasgow from the 1st to the 7th of July 2023 and represents one of the main congress for clinical and pharmacology innovations.
The congress will bring together scientists from across the world, thanks to a selected line-up of 484 speakers and chairs from 78 countries, each renowned for their expertise and leadership in pharmacology.
In the frame of this congress, Pr. Guido Ferlazzo (Professor of Professor of Immunology and General Pathology in the University Genova) delivered a lecture on “An exopolysaccharide from the marine bacillus licheniformis T14 (Symbiofilm) can prevent the adhesion of microorganisms to human nasal epithelial cells and impair biofilm formation”.
Lallemand Pharma is once more pleased to support as sponsor the spread the scientific knowledge as remarkable commitment to innovation and scientific progress to continue to provide solutions to patients needs.
Learn more about the congress:
Location: GLasgow - Scotland
From August 30, 2022 to August 30, 2022
The last Scientific Meeting of Lallemand Pharma was organized in Paris – France , on August 30th, 2022.
Lallemand Pharma invited Key Opinion Leaders and Scientific partners from all over Europe to review the last breakthroughs on the respiratory field in regard to our PMBL® (Polyvalent Mechanical Bacterial Lysates) and Healsea® line (Nasal spray medical devices containing our marine postbiotic Symbiofilm®).
After almost two years of e-meetings, it has been really pleasant to meet again in person to exchange clinical results, scientific opinions, strategic visions for future challenges.
Lallemand Pharma is pleased to thankful all attendees for their fruitful participation and great expertise.
Location: Paris, France
From November 27, 2021 to March 31, 2022
The 38th Italian Society of General Medicine Congress (SIMG) will virtually take place from November, the 27th 2021 to March the 31st, 2022 and represent the main italian medical congress for general practitioners. The ambitious theme of 2021 year is “Projects of re-birth and re-start for the General Medicine”.
In the frame of this congress, Pr Giovanni Di Perri (Professor of Infectious diseases, University of Turin, Italy) will deliver a video training “PREVENZIONE DELLE INFEZIONI DELLE VIE RESPIRATORIE: IL PARERE DELL’ESPERTO» (prevention of respiratory track infection: the expert opinion).
Lallemand Pharma is pleased to support as sponsor the spread the scientific knowledge within general practioners community about the prevention of respiratory infections.
Discover more information about the SIMG congress as scientific program on the website https://congresso2021.simgvirtualcongress.it
Location: Italy
From November 05, 2020 to November 06, 2020
In the frame of the forum of innovation and immunostimulant, two TV sessions will be organized by Merck, PMBL distributor in Mexico, and CMICA (Mexican College of Clinical Immunology and Allergy) in the coming days, and will be transmitted on CMICA TV.
On November 5th 2020, Pr Guido Ferlazzo, MD (Professor of General Pathology and Immunology – University of Messina, Italy), will give a lecture entitled “Respiratory immunity and how to prevent respiratory infections” from 8:25 to 8:55 am (UTC-6, local Mexican time).
A second lecture will be done on November 6th about “Are immunostimulant all the same?” from 8:25 to 8:55 am (UTC-6, local Mexican time).
If you want to learn more about immunity, you can follow and register to the event here: https://lnkd.in/d__D_Qx
Location: Mexico
From November 28, 2019 to November 30, 2019
The 36th Italian Society of General Medicine congress (SIMG) is taking place in Florence, in Italy from November 28th to 30th 2019. This is the main italian medical congress for General practitioners. The ambitious theme of 2019 year is “Projects and tools for the General Medicine of the future”.
In the frame of this congress, Pr Giovanni Di Perri (Professor of Infectious diseases, University of Turin, Italy) will give a lecture on November 28th during the session “Management of respiratory infections” titled “Respiratory infections: can we prevent them? How? The lecture will be moderated by Pr Guido Ferlazzo (Professor of General Immunology and Pathology, University of Messina, Italy). This session will be followed by the thematic on antibiotic resistance.
Lallemand Pharma is proud to sponsor the event on November 28th to support scientific knowledge within general practioners community about respiratory infections and antibiotic resistance spread. It is a fact, that doctors during their medical practice to manage respiratory infections are struggling with the need to rationalize the use of antibiotics, despite their responsibility to deliver efficient therapeutic answer to their patients. Prophylactic measures in respiratory infections have thus their legitimate place in this program of General Medicine of the Future: Management of respiratory infections.
Discover the information about the SIMG congress as scientific program, timetable : https://web.aimgroupinternational.com/2019/simg/
Location: Florence, Italy
From October 01, 2019 to October 01, 2019
[ERS congress] – This is our second announcement on Pr K.Janeczek (Department of Children’s Lung Diseases and Rheumatology, Poland) who will present a poster about « the effect of polyvalent mechanical bacterial lysate on the reduction of nasal Staphylococcus aureus carriage in children with pollen allergic rhinitis», on October 1st 2019 during the annual European Respiratory Society Congress (ERS) in Madrid, Spain.
If you want to attend, join the poster presentation from 12:50 to 14:40 pm at the IFEMA, session 460, PA4511.
Location: Madrid, Spain
From September 28, 2019 to October 02, 2019
The annual European Respiratory Society Congress (ERS) is a scientific society gathering scientists, clinicians and healthcare professionals from all over the world.
Every year, the ERS congress takes place in a different country as an excellent hub for communication and collaboration across the entire field of respiratory medicine. This year, the ERS International Congress 2019 will take place from September 28th to October 2nd in Madrid, Spain. The Congress programme will cover key topics in respiratory medicine from across the spectrum of 8 disease areas, including Tuberculosis, lung cancer, chronic and acute respiratory failure, sleep breathing disorders, interstitial lung diseases, pneumonia, cystic fibrosis, Chronic Obstructive Pulmonary Disease (COPD) and asthma….
In the frame of this congress, Pr Janeczek (Department of Children’s Lung Diseases and Rheumatology in Poland) will present a poster about « The effect of polyvalent mechanical bacterial lysate on the reduction of nasal Staphylococcus aureus carriage in children with pollen allergic rhinitis», on October 1st2019.
Location: Madrid, Spain
From September 14, 2019 to September 14, 2019
Do you know that respiratory tract infections are the most common infectious diseases and the main reason of consultations with general practitioners?
Family doctors are daily managing patients affected by respiratory infections, and have to take care of more and more patients with multiple comorbidities requiring quick and correct decisions. That’s why, prophylaxis shall be regarded as a part of the therapeutic arsenal in respiratory infections.
Our Italian partner, Zambon, will organize a Continuing Medical Education (CME) Event about “the prophylaxis and treatment of respiratory infections” in Turin, Italy, on September 14th 2019 intended for doctors specialized in General or internal medicine, diseases of the respiratory system, allergy or emergency.
This event will be in collaboration with two experts in infectious diseases and immunology of Lallemand Pharma: Pr G.Di Perri (Professor of Infectious diseases, University of Turin, Italy) and Pr G.Ferlazzo (Professor of General Immunology and Pathology – University of Messina, Italy).
Location: Turin, Italy
From June 01, 2019 to June 05, 2019
The EAACI (European Academy of Allergy and Clinical Immunology) Congress 2019 will be in Lisbon, Portugal from June 1st to 5th. This congress will help all attending delegates and participants to advance their knowledge and navigate the complex world of today’s allergy and clinical immunology.
In the frame of this congress, Pr Janeczek (Department of Children’s Lung Diseases and Rheumatology in Poland) will give a lecture about « PMBL in allergic rhinitis children », on June 3rd.
Location: Lisbon, Portugal
From June 01, 2019 to June 05, 2019
The EAACI (European Academy of Allergy and Clinical Immunology) Congress 2019 will be in Lisbon, Portugal from June 1st to 5th. This congress will help all attending delegates and participants to advance their knowledge and navigate the complex world of today’s allergy and clinical immunology.
In the frame of this congress, Pr Janeczek (Department of Children’s Lung Diseases and Rheumatology in Poland) will give a lecture about « PMBL in allergic rhinitis children », on June 3rd.
Location: Lisbon, Portugal
From June 01, 2019 to June 05, 2019
The EAACI (European Academy of Allergy and Clinical Immunology) Congress 2019 will be in Lisbon, Portugal from June 1st to 5th. This congress will help all attending delegates and participants to advance their knowledge and navigate the complex world of today’s allergy and clinical immunology.
In the frame of this congress, Pr Janeczek (Department of Children’s Lung Diseases and Rheumatology in Poland) will give a lecture about « PMBL in allergic rhinitis children », on June 3rd.
Location: Lisbon, Portugal
From February 02, 2018 to February 05, 2018
Lallemand Pharma is pleased to support as sponsor the XII World Congress on COPD, Asthma & Respiratory Allergy, to take place, February 2-5, 2018, Dubai, UAE, organized by the World Immunopathology Organization (WIPO).
During the congress, Professor Guido Ferlazzo (University of Messina, Italy), will deliver a presentation unveiling new potential mechanisms of action for polyvalent mechanical bacterial lysates, explaining their protective role in the reduction of the exacerbation episodes of both COPD and pediatric asthma.
For more information about WIPO congresses, visit www.wipocis.org
Location: Dubaï
September 09, 2017
Join us at ERS congress in Milano, Italy from September 9th-13th, 2017. Our latest pharmacoeconomic results will be presented at the poster session 137 on September 10th, from 12.50 to 14.40 during the thematic Poster “Pediatric asthma: therapies and comorbidities” :
The poster will be presented by Pr A.Bodajko-Grochowska (Lublin, Poland): “Cost of sublingual bacterial vaccines in the treatment of asthma in children“
Location: Milano, Italy
From June 17, 2017 to June 22, 2017
Lallemand Pharma is proud to announce poster session about EOLIA study during EAACI congress from 17-21 June in Helsinki, Finland.
Pr Andrzej Emeryk (Poland) will present “The influence of polyvalent mechanical bacterial lysate course on Asthma in Children” at 13.30 on June 20th , poster discussion Zone 1: category Asthma, Pediatrics, PDS 24 Pediatric Asthma.
Location: Helsinki, Finland
From April 28, 2017 to May 01, 2017
Lallemand Pharma is sponsoring the Xth World Asthma, Allergy and COPD forum which will take place in New-York, USA from April 28th-May 1st.
Website of the congress: http://wipocis.org/Page455.html
Location: New-York, USA
From December 12, 2013 to December 14, 2013
COPD: The new paradigms
Location: Monaco
Webiste: http://www.lung-health.org/